DalsnaFinance › Analyst accuracy › Stifel › IDYA target
Stifel initiates Ideaya Biosciences stock with buy rating
Stifel initiated coverage on Ideaya Biosciences Inc. (NASDAQ:IDYA) with a buy rating and set a price target of $48.00.
A fact about what Stifel published, as reported by Investing.com, not a recommendation from Dalsna Finance; Stifel is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.